OverviewSuggest Edit

Aerie Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases. It focuses on the development of products for the pharmaceutical treatment of glaucoma. The Company’s lead product candidate, AR-13324, is the first of a new dual action drug class that reduces the eye’s fluid inflow while also increasing fluid outflow through the trabecular meshwork, which is the eye’s main fluid drain, all in a highly effective single drop per day. Aerie’s PG324 fixed combination of AR-13324 with latanoprost is a first-in-class glaucoma therapy to lower intraocular pressure by reducing fluid inflow while also opening both of the eye’s fluid drains. This product candidate offers the convenience of two drugs in one eye drop.

TypePublic
Founded2005
HQIrvine, CA, US
Websiteaeriepharma.com
Employee Ratings3.3

Latest Updates

Employees (est.) (Dec 2019)380(+8%)
Job Openings20
Revenue (FY, 2020)$83.1 M(+19%)
Share Price (May 2021)$17.6(+2%)
Cybersecurity ratingBMore

Key People/Management at Aerie Pharmaceuticals

Richard J. Rubino

Richard J. Rubino

CFO
Vicente Anido

Vicente Anido

Chief Executive Officer and Chairman of the Board
David A. Hollander

David A. Hollander

Chief R&D Officer
Thomas A. Mitro

Thomas A. Mitro

President and Chief Operating Officer
Benjamin F. McGraw

Benjamin F. McGraw

Director
Casey C. Kopczynski

Casey C. Kopczynski

Chief Scientific Officer
Show more

Aerie Pharmaceuticals Office Locations

Aerie Pharmaceuticals has offices in Irvine, Bedminster, Durham, Dublin and in 2 other locations
Irvine, CA, US (HQ)
2030 Main Street #1500
Bedminster, NJ, US
550 Hills Dr 3rd floor
Durham, NC, US
4301 Emperor Blvd
Dublin, IE
28-32 Pembroke Street Upper
Chiyoda City, JP
1-chōme-11-1 Marunouchi
Henley-on-Thames, GB
Newtown Road The Henley Building
Show all (6)

Aerie Pharmaceuticals Financials and Metrics

Aerie Pharmaceuticals Revenue

Aerie Pharmaceuticals's revenue was reported to be $83.14 m in FY, 2020
USD

Revenue (Q1, 2021)

23.0m

Gross profit (Q1, 2021)

16.3m

Gross profit margin (Q1, 2021), %

70.8%

Net income (Q1, 2021)

(42.0m)

EBIT (Q1, 2021)

(34.2m)

Market capitalization (12-May-2021)

824.8m

Closing stock price (12-May-2021)

17.6

Cash (31-Mar-2021)

122.7m

EV

932.2m
Aerie Pharmaceuticals's current market capitalization is $824.8 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

24.2m69.9m83.1m

Cost of goods sold

641.0k22.8m25.3m

Gross profit

23.5m47.1m57.8m

Gross profit Margin, %

97%67%70%
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

2.4m7.3m10.9m15.8m18.5m20.3m18.0m20.1m23.0m

Cost of goods sold

59.0k205.0k381.0k705.0k2.1m6.1m6.7m

Gross profit

2.4m7.1m10.5m15.1m16.5m14.2m16.3m

Gross profit Margin, %

98%97%96%96%89%70%71%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

69.6m85.6m91.1m197.9m197.6m202.8m143.9m151.6m

Accounts Receivable

399.0m2.7m38.4m56.0m

Prepaid Expenses

4.5m4.5m7.7m8.3m

Inventories

618.0k1.1m1.9m4.0m10.1m21.1m27.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

4.6m35.8m27.9m148.9m113.5m100.9m106.9m74.3m58.5m211.9m139.5m242.7m194.1m249.5m270.6m235.0m148.9m109.4m248.7m134.2m151.3m129.8m122.7m

Accounts Receivable

1.1m2.0m14.8m25.7m33.3m42.9m43.1m46.8m46.2m

Prepaid Expenses

117.0k672.0k930.0k656.0k1.2m1.1m1.3m1.4m1.2m2.9m2.4m2.1m2.1m6.1m2.5m3.3m6.5m8.7m7.9m10.5m9.0m9.1m10.9m

Inventories

1.1m5.7m5.6m10.2m10.4m14.7m20.2m19.1m20.8m28.3m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(31.1m)(48.1m)(74.4m)(99.1m)(145.1m)(232.6m)(199.6m)(183.1m)

Depreciation and Amortization

64.0k73.0k252.0k970.0k1.4m13.0m34.2m

Inventories

(9.7m)(10.3m)(5.2m)

Accounts Payable

2.0m551.0k925.0k26.6m28.8m22.5m
USDQ3, 2013

Financial Leverage

-0.1 x
Show all financial metrics

Aerie Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

B

81/100

SecurityScorecard logo

Aerie Pharmaceuticals Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Aerie Pharmaceuticals Online and Social Media Presence

Embed Graph

Aerie Pharmaceuticals News and Updates

Corneal Endothelial Dystrophy (CED) 11 Year Forecasts, 7MM Coverage, Key Cross Competition, Featuring Aerie Pharmaceuticals, Kowa Pharmaceuticals and Trefoil Therapeutics

Dublin, April 06, 2021 (GLOBE NEWSWIRE) -- The "Corneal Endothelial Dystrophy Market Insights, Epidemiology, and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of Corneal Endothelial Dystrophy (CED), histor…

Aerie Pharmaceuticals Frequently Asked Questions

  • When was Aerie Pharmaceuticals founded?

    Aerie Pharmaceuticals was founded in 2005.

  • Who are Aerie Pharmaceuticals key executives?

    Aerie Pharmaceuticals's key executives are Richard J. Rubino, Vicente Anido and David A. Hollander.

  • How many employees does Aerie Pharmaceuticals have?

    Aerie Pharmaceuticals has 380 employees.

  • What is Aerie Pharmaceuticals revenue?

    Latest Aerie Pharmaceuticals annual revenue is $83.1 m.

  • What is Aerie Pharmaceuticals revenue per employee?

    Latest Aerie Pharmaceuticals revenue per employee is $218.8 k.

  • Who are Aerie Pharmaceuticals competitors?

    Competitors of Aerie Pharmaceuticals include Ascletis, Biosearch Life and Olainfarm.

  • Where is Aerie Pharmaceuticals headquarters?

    Aerie Pharmaceuticals headquarters is located at 2030 Main Street #1500, Irvine.

  • Where are Aerie Pharmaceuticals offices?

    Aerie Pharmaceuticals has offices in Irvine, Bedminster, Durham, Dublin and in 2 other locations.

  • How many offices does Aerie Pharmaceuticals have?

    Aerie Pharmaceuticals has 6 offices.